| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FAM135A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | ATF4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | RAB3A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | PSMD14 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PCDHGC4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | RGPD5 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | PRELID3A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | EML3 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | CCHCR1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | ISL2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
